Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vor Biopharma Inc
(NQ:
VOR
)
0.7255
-0.0095 (-1.29%)
Streaming Delayed Price
Updated: 2:57 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
487,464
Open
0.7547
Bid (Size)
0.7210 (2)
Ask (Size)
0.7300 (3)
Prev. Close
0.7350
Today's Range
0.7132 - 0.7665
52wk Range
0.7000 - 3.140
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
September 10, 2024
Via
Benzinga
What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?
September 06, 2024
Vor Biopharma reveals promising Phase 1/2 study results for AML treatment, and it is planning FDA pivotal trial discussions.
Via
Benzinga
Exposures
Product Safety
Performance
YTD
-67.47%
-67.47%
1 Month
-18.50%
-18.50%
3 Month
-36.36%
-36.36%
6 Month
-69.39%
-69.39%
1 Year
-65.45%
-65.45%
More News
Read More
Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
September 06, 2024
Via
Benzinga
New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
September 05, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Biopharma: Q4 Earnings Insights
March 20, 2024
Via
Benzinga
Vor Bio to Participate in Upcoming Investor Conferences
August 28, 2024
From
Vor Biopharma
Via
GlobeNewswire
VOR Stock Earnings: Vor Biopharma Beats EPS for Q2 2024
August 09, 2024
Via
InvestorPlace
Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update
August 08, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 09, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2024
From
Vor Biopharma
Via
GlobeNewswire
VOR Stock Earnings: Vor Biopharma Beats EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
May 09, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
May 06, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
May 02, 2024
From
Vor Biopharma
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 05, 2024
Via
Benzinga
Vor Bio to Participate in Upcoming Investor Conferences
April 01, 2024
From
Vor Biopharma
Via
GlobeNewswire
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
March 28, 2024
Via
InvestorPlace
VOR Stock Earnings: Vor Biopharma Beats EPS for Q4 2023
March 20, 2024
Via
InvestorPlace
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
March 20, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
March 04, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 07, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2024
From
Vor Biopharma
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.